Is tirzepatide measured in units or milligrams?
When someone asks about tirzepatide dosage in units, they usually mean one of two things. Either they are asking about the milligram dose prescribed by their clinician, or they are asking how much to draw into a syringe, which they are colloquially calling “units.”
In pharmacology, a “unit” is a quantity specific to the drug and is only meaningful when the drug is measured that way, as with insulin or heparin. Tirzepatide is dosed in milligrams (mg). If you draw up tirzepatide in a syringe, you are drawing a volume of liquid (measured in milliliters or in the tick marks on an insulin syringe) that corresponds to a milligram dose, based on the concentration of your preparation.
That concentration is specific to your dispensed vial. A compounded tirzepatide preparation at 2.5 mg/mL requires a different drawn volume than one at 5 mg/mLto deliver the same dose. This is why calculating “how many units to draw” without knowing your vial concentration is not possible, and why your pharmacy and clinician provide those instructions directly.
What does a typical tirzepatide titration schedule look like?
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Clinical protocols for weight management typically begin at the lowest effective dose and titrate upward on a scheduled basis, primarily to allow the GI system to adjust. The most commonly described titration pattern in published research is:
- Weeks 1–4: 2.5 mg once weekly
- Weeks 5–8: 5 mg once weekly
- Weeks 9–12: 7.5 mg once weekly (if tolerated and clinically appropriate)
- Weeks 13 and beyond: 10 mg, 12.5 mg, or 15 mg as directed, based on response and tolerability
These are general patterns from the published SURMOUNT and SURPASS trial protocols. Your clinician may prescribe a different titration pace depending on your tolerance, health history, and weight management goals. The appropriate dose is always an individual clinical determination.
Most people find the GI side effects (nausea, decreased appetite, and occasional GI discomfort) most pronounced at each dose step-up, tapering within the first week at the new dose. Slower titration is always an option if tolerability is a concern.
How does compounded tirzepatide differ from branded products?
Tirzepatide is the active peptide in Mounjaro (approved for glycemic management in type 2 diabetes) and Zepbound (approved for weight management). Compounded tirzepatide is not the same product as those branded medications.
Compounded tirzepatide is prepared by a licensed 503A compounding pharmacy as a patient-specific formulation. It is not manufactured by Eli Lilly, it is not FDA-approved as a finished drug, and its quality is governed by USP compounding standards rather than the branded drug approval pathway. It is legally available through clinician prescription when the branded product is unavailable or access is otherwise constrained.
PepScribe’s compounded tirzepatide is sourced from licensed 503A pharmacies in the USA. No hidden overseas supply chain.
What factors determine your specific tirzepatide dose?
A prescribing clinician considers several factors when setting a tirzepatide starting dose and titration plan:
- Current body weight and BMI— not because dose scales with weight, but because weight management goals and clinical eligibility thresholds inform the protocol.
- Presence of type 2 diabetes or prediabetes— which affects safety monitoring, particularly around blood glucose.
- History of pancreatitis, thyroid conditions, or MEN2— which are contraindications or require extra caution.
- Current medications— especially anything that affects blood sugar or requires precise dosing stability.
- GI tolerability history— some individuals tolerate faster titration; others benefit from a slower schedule.
This is why the clinician review step is not a formality. The dosing decision is individualized, not a default that any given tool or chart can substitute for.
How do you give a subcutaneous tirzepatide injection?
Tirzepatide is administered subcutaneously, meaning the injection goes into the fatty tissue just beneath the skin. Common injection sites are the abdomen, upper thigh, and upper arm. Rotating sites reduces local tissue irritation.
The mechanics of drawing up a compounded tirzepatide injection:
- Confirm your prescribed dose in mg from your clinician.
- Note the concentration on your vial (e.g., 2.5 mg/mL, 5 mg/mL, or 10 mg/mL).
- Calculate the volume: Dose (mg) divided by concentration (mg/mL) = volume in mL. Your pharmacy or clinician provides this conversion pre-calculated.
- Draw to the correct syringe marking and administer as instructed.
Never dose from a vial that has changed color, is cloudy when it should be clear, or has visible particles. Contact your pharmacy if you have concerns about your preparation.
Frequently asked questions
What does tirzepatide dosage in units mean?
Tirzepatide is measured in milligrams (mg), not international units (IU or units) like insulin. When people ask about "units," they are typically asking how to read a syringe for subcutaneous injection. The drawn-up volume in the syringe corresponds to a milligram dose set by the prescribing clinician based on your specific concentration vial.
What is a typical tirzepatide starting dose?
Clinical protocols typically begin at 2.5 mg per week subcutaneously, with planned titration upward over several weeks based on tolerance and response. The specific titration schedule is determined by the prescribing clinician and varies by individual health history and goals.
How do I calculate how many units to draw for a tirzepatide injection?
The volume you draw depends on the concentration of your compounded preparation. Your prescribing clinician or the dispensing pharmacy provides conversion instructions specific to your vial. Never calculate units independently without guidance from the clinician or pharmacist who dispensed the medication.
Is tirzepatide the same as Mounjaro or Zepbound?
Tirzepatide is the active ingredient in Mounjaro and Zepbound. Compounded tirzepatide is not the same product as those branded medications — it is prepared by a licensed 503A pharmacy as a patient-specific formulation, is not manufactured by Eli Lilly, and is not FDA-approved as a finished drug. It is a distinct compounded preparation governed by USP compounding standards.
Can I adjust my tirzepatide dose on my own?
No. Dose adjustments should only be made in consultation with your prescribing clinician. Self-adjusting carries risks of GI side effects, hypoglycemia in susceptible individuals, and other adverse responses. Regular check-ins are part of a safe tirzepatide protocol.
Does compounded tirzepatide require refrigeration?
Most compounded tirzepatide preparations require refrigeration. Your dispensing pharmacy will provide specific storage instructions. Do not freeze the preparation unless explicitly instructed.